Substance use disorder: contraceptive options counseling

What’s New in Contraception?

Contraceptive Technology Conference!

Biologic sexism of STIs

Excess breast cancer deaths after COVID-19

Contraception for patients with medical conditions

Pelvic Floor Dysfunction

Treating vulvodynia

Puzzling Over the Hurt Down-Under

Serious Mental Illness and Contraception

New 13-Cycle Vaginal Contraceptive System

The Future of Family Planning in Post-COVID America

New ASCCP Guidelines: Implications for FP

On the alert: mood disorders during 2020 stressors

Sex in the Time of COVID-19

Challenges old and new during the pandemic

Reproductive health in the time of Covid-19

Talking about toys

Missed Pills: The Problem That Hasn’t Gone Away

Find the “yes! . . . and” rather than “no” or “but”

Digital Family Planning: the Future is Now

Irregular Bleeding Due to Contraceptives

When she’s low on libido…

Ouch! Best approaches to menstrual pain

Contraceptive efficacy: understanding how user and method characteristics play their part

Strategizing treatment for chronic heavy menstrual bleeding


Untangling the literature on obesity and contraception

High tech apps for no-tech FABM

Menstrual exacerbation of other medical conditions

From Princeton University: Thomas James Trussell (1949-2018)

The Short and Long of IUD Use Duration

Selecting a Method When Guidance Isn’t Clear-cut

Healthcare in the Time of Digital Expansion

The Scoop on Two New FDA-Approved Contraceptive Methods

Pregnancy of unknown location—meeting the challenge

Big “yes” (with caveats) to CHCs during perimenopause

The role of IUDs (LNG IUDs, too!) in emergency contraception

Combined pills’ effect on mood disorders

Abortion in the U.S.: safe, declining, and under threat

Hope for ovarian cancer screening test

Breast cancer still a small risk with some hormonal contraceptives

New treatment modality for BV

Record rate of HPV-related throat cancer

Viruses in semen potentially transmissible

Don’t Abstain from Your Role in Abstinence

Teens births declining but geographic ‘hotspots’ defy trend

Online Medical Abortion Service Effective and Safe

Do Women Really Need to Wait That Long?

Reassuring news on depression and OC use

PMDD: Genetic clues may lead to improved treatment

Breast cancer risk when there is a family history

Body weight link to breast and endometrial cancers (and 11 others)

Family Planning in 2017 and Beyond

Make Me Cry: Depression Link (Again)?

Managing implant users’ bleeding and spotting

Zika: Updated guidance for providers

Pharmacist-prescribed contraceptives

Hot off the press! 2016 MEC and SPR

Zika virus fears prompt increased request for abortion in nations outlawing abortions

Opioid use epidemic among reproductive-age women

Good news on the family planning home front!

War Against Planned Parenthood Hurts Women

Win-win for both treatment and prevention

Center of the Storm


Menopause, mood, mental acuity, and hormone therapy

Emergency contraception for teens

Postpartum Contraception: Now, Not Later

Reproductive tract infections, sexually transmitted infections, or sexually transmitted diseases: “a rose by any other name…”

Are we practicing what we preach?

Be alert to VTE in hormonal contraceptive users

LARC among teens increased 15-fold, but not enough

Brain cancer and hormonal contraception

Free tools: Easy access to the US Medical Eligibility Criteria for Contraceptive Use

Alcohol consumption when pregnancy is unwanted or unintended

Latest Data on Contraceptive Use in the United States

LateBreaker sampler from Contraceptive Technology conference

Emergency Contraceptive Pill Efficacy and BMI/Body Weight

Handout on Unintended Pregnancy and Contraceptive Choice

Ask About Withdrawal (Really!)

Rules to Practice By: Safety First and Cleanliness is Close to. . .

What’s Vanity Fair Got Against the NuvaRing?

Promising New Treatment for Hepatitis C

Numbers matter, so make them simple for patients

The Recession’s Effect on Unintended Pregnancies

Lessons Learned from the Contraceptive CHOICE Project: The Hull LARC Initiative

Applying the “New” Cervical Cytology Guidelines in Your Practice

Acute Excessive Uterine Bleeding: New Management Strategies

Medical indications for IUD use in teens

Whatever happened to PID?

Update on Emergency Contraception New and Improved

Medical indications for IUD use in teens
December 2013


Beyond offering excellent contraceptive protection and several noncontraceptive benefits. However, many women are unaware that adolescents can safely use IUDs. Although IUD use increased dramatically, by more than tenfold, use remains exceedingly low at only 2.5%.[1]

Recently reporting on the St. Louis CHOICE project, in which women are offered long-acting reversible contraceptives without charge as a first-line option, Jeffrey Peipert, MD, PhD, reported that the birth rate for teens ages 15-19 years enrolled in the study was 6.1 per 1,000, a rate far below the national average of 34.3 per 1,000.[2] The study team found that teens’ rate continuation and reported satisfaction with IUDs did not differ from that of adult users. In fact, more than 80% of adolescents using the LNG-IUS, the copper IUD, and implants continued use for a full year. In contrast the 12-month continuation rate among teens using non-LARC methods was only about 50%. Although the younger teens ages 14-17 years in the project were more likely to select the implant than the IUD as their method, older teens ages 18-20 years were twice as likely to select an IUD over an implant.

A number of studies among adult women have shown that the levonorgestrel intrauterine system (LNg-IUS) can for most users reduce menstrual bleeding, decrease dysmenorrhea, suppress endometriosis, and offer endometrial protection against chronic anovulation.[3] In a recent review, Bayer and Hillard concluded that these same benefits for medical management of menstrual-related problem likely apply to adolescents as well. One of the most common problems in adolescents is heavy menstrual bleeding, which may require a change in tampon or pad every hour or two or may last longer than a week. One study of young women ages 18-25 found that IUD users reported less bleeding than did COC users.[4]

Most adolescents report dysmenorrhea (60-93%). A randomized trial of young women 18-25 years showed that LNG-IUS users had greater alleviation of dysmenorrhea than did pill users. In the rare case of an adolescent who may be at risk of  endometrial hyperplasia, and so may benefit from endometrial protection, may be better managed by LNG-IUS than by pills because she may have risk of deep venous thrombosis or, simply, poor compliance and high discontinuation. The menstrual suppression accompanying LNG-IUS use may be a promising benefit for adolescents with mental retardation and developmental disorders, for whom menstrual cycling represents unique challenges with hygiene and behavioral concerns. However, this particular population may require anesthesia for IUD insertion.

[1] Whitaker AK, Sisco KM, Tomlinson AN, Dude AM, Martins SL. Use of the  intrauterine device among adolescent and young adult women in the United States from 2002 to 2010. J Adol Health 2013;53:401-6.

[2] Peipert JF. The importance of long-acting reversible contraception (LARC). Presented March 14, 2013 at the Contraceptive Technology conference, San Francisco, CA.

[3] Bayer LL, Hillard PJA. Use of levonorgestrel intrauterine system for medical indications in adolescents. J Adol Health 2013;52:S54-8.

[4] Suhonen S, Jaukkamaa M, Jakobsson R, et al. clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women. Contraception 2004;69:407-12

–Deborah Kowal, MA, PA, President & CEO, Contraceptive Technology Communications, Inc.